6.11

3.38% 0.20

Capsovision Inc (CV)

Overview News Price History Discussions Forecast

Capsovision Inc stock is traded at $6.11, with a volume of 24,399. It is up +3.38% in the last 24 hours and down -12.96% over the past month. CapsoVision Inc is a commercial-stage medical technology enterprise that innovates, manufactures, and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal (GI) system. The company's core technology platform is an orally ingestible capsule including multiple cameras facilitating 360-degree imaging, light-emitting diodes for measurement, onboard memory storage, and battery life permitting recording and onboard storage of video images. CapsoVision's products consist of the on-market CapsoCam Plus, directed at the small intestines, and the in-development CapsoColon 3D, directed at the large intestines. Geographically, the company generates the majority of its revenue from the United States.

Previous Close:

$5.91

Open:

$5.95

24h Volume:

24,399

Relative Volume:

0.17

Market Cap:

$305.79M

Revenue:

$13.56M

Net Income/Loss:

$-26.97M

P/E Ratio:

-10.64

EPS:

-0.5742

Net Cash Flow:

$-24.04M

1W Performance:

-5.42%

1M Performance:

-12.96%

6M Performance:

+30.56%

1Y Performance:

+53.52%

1-Day Range:

$5.86

$6.1352

1-Week Range:

$5.86

$6.755

52-Week Range:

$3.4341

$15.37

Capsovision Inc Stock (CV) Company Profile

Name

Capsovision Inc

Sector

Healthcare (1086)

Industry

Medical Devices (140)

Phone

(408) 370-4790

Address

18805 COX AVENUE SUITE 250, SARATOGA

Employee

Twitter

Next Earnings Date

2026-08-13

Latest SEC Filings

CV's Discussions on Twitter

Compare CV vs ABT, SYK, MDT, BSX, EW

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
CV Capsovision Inc	6.11	306.29M	13.56M	-26.97M	-24.04M	-0.5742
ABT Abbott Laboratories	116.12	198.01B	46.59B	5.41B	7.38B	3.0938
SYK Stryker Corp	330.26	130.41B	25.27B	3.34B	4.57B	8.6334
MDT Medtronic Plc	93.14	120.48B	36.36B	4.84B	5.43B	3.7261
BSX Boston Scientific Corp	50.73	75.37B	20.62B	3.56B	3.48B	2.3847
EW Edwards Lifesciences Corp	89.89	53.19B	6.30B	1.07B	1.09B	1.8406

Capsovision Inc Stock (CV) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jul-28-25	Initiated	Roth Capital	Buy
Jul-28-25	Initiated	The Benchmark Company	Speculative Buy

Capsovision Inc Stock (CV) Latest News

Aug 20, 2026

CapsoVision (CV) Earnings Update: The Bottom-Line Figure Trails Its Comparison; Latest Reaction: The Stock Ends Down 0.49%Basic EPS Analysis - Vinanet

Aug 20, 2026

Aug 18, 2026

CapsoVision Initiates $100 Million At-the-Market Equity Offering with Cantor Fitzgerald - Kalkine Media

Aug 18, 2026

CapsoVision Launches $100 Million At-The-Market Offering - TipRanks

Aug 18, 2026

CapsoVision launches $100M at-the-market equity program with Cantor Fitzgerald - TradingView

Aug 18, 2026

Aug 17, 2026

The CapsoVision, Inc. (NASDAQ:CV) Second-Quarter Results Are Out And Analysts Have Published New Forecasts - 富途牛牛

Aug 17, 2026

Aug 14, 2026

CapsoVision Earnings Call: Growth, AI Push, Margin Strain - TipRanks

Aug 14, 2026

CapsoVision stock rating maintained at Speculative Buy by Benchmark - Investing.com

Aug 14, 2026

CapsoVision (CV) Q2 2026 Earnings Call: Umsatz steigt um 10 %, KI-Einführung schreitet voran - TradingKey

Aug 14, 2026